NEW YORK, Nov. 21, 2019 /PRNewswire/ -- WeissLaw
LLP is investigating possible breaches of fiduciary duty and
other violations of law by the Board of Directors of Proteon
Therapeutics, Inc. ("PRTO" or the "Company") (NASDAQ: PRTO) in
connection with the proposed acquisition of the Company by ArTara
Therapeutics, Inc.
If you own PRTO shares and wish to discuss
this investigation or have any questions concerning this notice or
your rights or interests, visit our website:
http://www.weisslawllp.com/proteon-therapeutics-inc/
Or please contact:
Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com
WeissLaw is investigating whether PRTO's Board acted to maximize
shareholder value prior to entering into the acquisition
agreement. Notably, at close of the transaction, PRTO
shareholders will own a meager 10% of the combined
company.
Additionally, the Company recently announced significant
improvements in its financial results for the third quarter of
2019. It reported a net loss of $1.5
million, representing an improvement of $3.00 million year-over-year when compared to the
$4.5 million it reported in the same
period of the previous year.
Given these facts, WeissLaw is concerned whether the proposed
acquisition undervalues the Company, and whether all material
information related to the proposed acquisition is fully and fairly
disclosed.
WeissLaw LLP has litigated hundreds of stockholder class and
derivative actions for violations of corporate and fiduciary
duties. We have recovered over a billion dollars for
defrauded clients and obtained important corporate governance
relief in many of these cases. If you have information or
would like legal advice concerning possible corporate wrongdoing
(including insider trading, waste of corporate assets, accounting
fraud, or materially misleading information), consumer fraud
(including false advertising, defective products, or other
deceptive business practices), or anti-trust violations, please
email us at stockinfo@weisslawllp.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-investigates-proteon-therapeutics-inc-300963398.html
SOURCE WeissLaw LLP